What's new

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Mar 12, 2025 - 17:06
 0
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/202...

Next Article

Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/202...

Related Posts

Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib, Date of authorisation: 15/09/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Herbal medicinal product: Eucalypti aetheroleum, Eucalyptus globulus Labill.,Eucalyptus polybractea  R.T. Baker,Eucalyptus smithii  R.T. Baker, F: Assessment finalised

Herbal medicinal product: Eucalypti aetheroleum, Eucaly...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0